Atomoxetine Dosing for ADHD in Adults
For adults with ADHD, start atomoxetine at 40 mg daily and increase after a minimum of 3 days to a target dose of 80 mg daily, with a maximum of 100 mg daily if needed after 2-4 additional weeks at the target dose. 1
Standard Dosing Algorithm
Initial Dosing
- Starting dose: 40 mg once daily (morning) or divided into morning and late afternoon/evening doses
- Wait minimum 3 days before titration 1
Target Dosing
- Target dose: 80 mg daily (reached after minimum 3 days)
- Can be given as single morning dose OR divided (morning + late afternoon/evening)
- Maintain at 80 mg for 4-6 weeks before judging efficacy 2, 3
Maximum Dosing
- After 2-4 additional weeks at 80 mg, may increase to maximum 100 mg daily if response inadequate 1
- Critical caveat: No data support increased effectiveness at doses higher than 80 mg 1
Dosing Adjustments for Special Populations
Hepatic Impairment
Atomoxetine clearance is significantly reduced in hepatic impairment, requiring dose reduction 4:
- Moderate hepatic impairment (Child-Pugh Class B): Reduce initial and target doses to 50% of normal (start 20 mg, target 40 mg) 1
- Severe hepatic impairment (Child-Pugh Class C): Reduce initial and target doses to 25% of normal (start 10 mg, target 20 mg) 1
CYP2D6 Poor Metabolizers or Strong CYP2D6 Inhibitor Use
Approximately 7% of the population are CYP2D6 poor metabolizers with significantly higher plasma levels 5:
- Initial dose: 40 mg daily
- Only increase to 80 mg if symptoms fail to improve after 4 weeks AND initial dose is well tolerated 1
- Strong CYP2D6 inhibitors include paroxetine, fluoxetine, and quinidine 1
Clinical Implementation Pearls
Dosing Schedule Flexibility
- Once daily dosing (morning) is standard and convenient for adherence
- Twice daily dosing (morning + late afternoon/evening) may reduce nausea—the BID group showed significantly lower nausea rates (16.4% vs 32.4%) compared to QD dosing 6
- Can dose in evening only if needed to minimize daytime side effects 5
Duration Considerations
- Onset of effect: 6-12 weeks for full therapeutic benefit 5—much slower than stimulants
- Adequate trial duration: Maintain at target dose for 4-6 weeks minimum before declaring treatment failure 2
- Real-world data show only 45% of adults reach the recommended 80 mg dose, which correlates with significantly shorter treatment duration (65.6 vs 159.3 days) 3
Common Pitfalls to Avoid
- Underdosing: Average real-world dose is ~60 mg, well below the 80 mg target 2—this suboptimal dosing leads to premature discontinuation
- Premature discontinuation: Patients reaching 80 mg had 93.8 more days of therapy than those who didn't 3
- Inadequate trial duration: Must wait full 4-6 weeks at target dose before assessing efficacy 2
- Ignoring CYP2D6 status: SSRIs (paroxetine, fluoxetine) can dramatically increase atomoxetine levels 5
Safety Monitoring
Cardiovascular
- Monitor blood pressure and heart rate—atomoxetine increases both 5
- Use caution in hypertension, tachycardia, or cardiovascular disease 5
Hepatic
- Black box warning for hepatotoxicity: Discontinue immediately if jaundice or laboratory evidence of liver injury develops 7
- Atomoxetine shows higher reporting frequency of hepatobiliary disorders compared to methylphenidate (ROR 2.41) 7
Psychiatric
- Monitor for emergence of psychotic/manic symptoms, aggressive behavior, or hostility 5
- Screen for bipolar disorder before initiating treatment 1
- Note: Unlike in children/adolescents, adult trials did NOT show increased suicidal ideation 5
Other Monitoring
- Urinary retention: Monitor for urinary hesitancy, particularly in males 5
- Priapism: Rare but requires immediate medical attention 5
- Common side effects: Dry mouth, constipation, nausea, fatigue, decreased appetite, dizziness, erectile dysfunction 1